| PERFLUTREN | None | ||
| 13.04MG/2ML |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| DEFINITY RT is an ultrasound contrast agent indicated for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border. | |||
|
Yes
| |||
| DEFINITY RT | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||||||||||
| ******* *** ****** ********** ******** ****** | *****-************ *** *********** ************ *** ******* ******* | *****-************ *** *********** ************ *** ******* ******* | ******* *** ****** ********** ******** ****** | ******* *** ******* *** *********** ** ********** ******** ****** | ******* *** ****** ********** ******** ****** | *****-************ *** *********** ************ *** ******* ******* | ******* *** ****** ********** ******** ****** | ******* *** ****** ********** ******** ****** | ******* *** ****** ********** ******** ****** | ******* *** ****** ********** ******** ****** | ***-****** ***** ******* *** *** ** ********** *** *********** ************ | *** ****** ********* *** ********** *** ******* *** ***** *** ** ********** ******** ****** | *** ******* ************ *** ***** *** ** ******** ****** *** ******** **********, *** ** ***** ************ | *** ******* ************ *** ***** *** ** ******** ****** *** ******** ********** *** ** ***** ************ | ******** ***** ********** *** ******* ************ | ****** ** ********* *** *** ******* *********-****** ************ | *** ******* ************ *** *********** *** ***** *** ** ******** ****** *** ******** ********** *** ** ***** ************ | ******* *** ********** ******* ** ********** *** ************** **** ** * ******** ***** | *********** ** * ***** ***** *** * ************ ********** ********** *** ***** ***** | *********** ** * ***** ***** *** * ************ ********** ********** *** ***** ***** | *********** ** * ***** ***** *** * ************ ********** ********** *** ***** ***** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|